Clinical Trials Browser

Phase 2 × INDUSTRY × Mesalamine × Clear all

NCT02077777 2016-12-02

Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.

Phase 2 Completed

Gastrointestinal

Neoplasms, Colorectal Neoplasms